Advertisement

Organisation › Details
Wacker (Group)
![]() |
Industry | CHEMICALS |
Industry 2 | contract manufacturing (biologicals) | |
![]() |
Person | Hartel, Christian (Wacker 202206 CEO) |
Person 2 | Staudigl, Rudolf (Wacker 201602 CEO) | |
![]() |
Region | München (Munich) |
Country | Germany | |
Street | 4 Hanns-Seidel-Platz | |
City | 81737 München | |
Tel | +49-89-6279-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 5,295,000,000 (sales, consolidated (2015) 2015-12-31) | |
Profit | 240,000,000 (2015-12-31) | |
Record changed: 2024-12-29 |
Advertisement

More documents for Wacker (Group)
- [1] Wacker Chemie AG. (12/17/24). "Press Release: Wacker Biosolutions under New Leadership". Munich....
- [2] Wacker Chemie AG. (6/19/24). "Press Release: Wacker & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification". Munich, Halle (Saale) & Basel....
- [3] Wacker Chemie AG. (6/3/24). "Press Release: Wacker Opens mRNA Competence Center in Halle an der Saale, Germany". Munich & Halle (Saale)....
- [4] Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA....
- [5] Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf....
- [6] Wacker Chemie AG. (5/8/23). "Press Release: Wacker Purchases ADL BioPharma in Spain, Strengthening Its Biotechnology Business". Munich & León....
- [7] Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn....
- [8] Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA....
- [9] Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich....
- [10] mk2 Biotechnologies GmbH. (6/7/22). "Press Release: mk2 Biotechnologies, Wacker and TUM Jointly Develop a Process for the Large-scale Production of Antimicrobial Peptides Based on Sustainable Fermentation"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top